MedTrace Logo

Oral Ginkgo Biloba and Narrow Band UVB in the Treatment of Vitiligo

NCT01006421 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2009-11-05

No results posted yet for this study

Summary

Vitiligo is a common chronic skin disease with 1-4% prevalence. It has a significant psychosocial impact on patients and society. Different treatment modalities with variable success rates are available.

Phototherapy is among the successful treatments but gives modest results. Some reports documented the usefulness of Ginkgo Biloba (GB) when used alone in Vitiligo treatment.

Conditions

  • Vitiligo

Interventions

DIETARY_SUPPLEMENT

GINGKO BILOBA

MEMOREX 60 MG BID

Sponsors & Collaborators

  • University Hospital

    collaborator OTHER

  • King Saud University

    lead OTHER

Principal Investigators

  • KHALID M ALGHAMDI, MD · KSU

Eligibility

Min Age
12 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Completion
2011-01-31

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01006421 on ClinicalTrials.gov